Ulipristal acetate: a guide to its use in emergency contraception


    loading  Checking for direct PDF access through Ovid

Abstract

Ulipristal acetate, the first of a new class of selective progesterone receptor modulators, is indicated for emergency contraception within 120 hours of unprotected sexual intercourse or contraceptive failure. In clinical trials, a single oral dose of ulipristal acetate was effective in preventing pregnancies in women requesting emergency contraception and provided sustained efficacy throughout the 120-hour postcoital period.

    loading  Loading Related Articles